While Staar Surgical Co. has overperformed by 2.93%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, STAA fell by -43.00%, with highs and lows ranging from $73.13 to $26.66, whereas the simple moving average fell by -22.12% in the last 200 days.
On December 05, 2023, Needham Downgraded Staar Surgical Co. (NASDAQ: STAA) to Hold. A report published by Morgan Stanley on December 04, 2023, Initiated its previous ‘Equal-Weight’ rating for STAA. Canaccord Genuity August 03, 2023d the rating to Hold on August 03, 2023, and set its price target from $77 to $48. William Blair June 07, 2023d its ‘Outperform’ rating to ‘Mkt Perform’ for STAA, as published in its report on June 07, 2023. Piper Sandler’s report from April 17, 2023 suggests a price prediction of $65 for STAA shares, giving the stock a ‘Neutral’ rating. BTIG Research also rated the stock as ‘Neutral’.
Analysis of Staar Surgical Co. (STAA)
Further, the quarter-over-quarter increase in sales is 19.09%, showing a positive trend in the upcoming months.
To gain a thorough understanding of Staar Surgical Co.’s future performance, several well-rounded types of analysis and research techniques can be used, with equity being among the most crucial. The goal here is to ensure that your current return on equity of 5.95% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 5.08, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
It is also very valuable to look at average volume as an indicator of volatility for a stock, and STAA is recording an average volume of 793.49K. On a monthly basis, the volatility of the stock is set at 5.10%, whereas on a weekly basis, it is put at 5.41%, with a gain of 6.14% over the past seven days. Furthermore, long-term investors anticipate a median target price of $42.25, showing growth from the present price of $32.68, which can serve as yet another indication of whether STAA is worth investing in or should be passed over.
How Do You Analyze Staar Surgical Co. Shares?
A leading company in the Medical Instruments & Supplies sector, Staar Surgical Co. (STAA) is based in the USA. When comparing Staar Surgical Co. shares with other companies under Healthcare, the P/E value is an influential factor to note. This is because it represents an indication of the future growth of the company in terms of investors’ expectations. Ultimately, the value of the latter should demonstrate steady, rapid growth, which is an accurate measure of the company’s progress. In addition to the value of 75.60, there is a growth in quarterly earnings of 32.91%.
The number of employees owning shares of the company should also be considered in addition to the fundamentals. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 1.06%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 105.68% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
STAA shares are owned by institutional investors to the tune of 105.68% at present.
